Cargando…
The Breast Cancer Oncogene EMSY Represses Transcription of Antimetastatic microRNA miR-31
Amplification of the EMSY gene in sporadic breast and ovarian cancers is a poor prognostic indicator. Although EMSY has been linked to transcriptional silencing, its mechanism of action is unknown. Here, we report that EMSY acts as an oncogene, causing the transformation of cells in vitro and potent...
Autores principales: | Viré, Emmanuelle, Curtis, Christina, Davalos, Veronica, Git, Anna, Robson, Samuel, Villanueva, Alberto, Vidal, August, Barbieri, Isaia, Aparicio, Samuel, Esteller, Manel, Caldas, Carlos, Kouzarides, Tony |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cell Press
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3988886/ https://www.ncbi.nlm.nih.gov/pubmed/24582497 http://dx.doi.org/10.1016/j.molcel.2014.01.029 |
Ejemplares similares
-
The Breast Cancer Oncogene EMSY Represses Transcription of Antimetastatic microRNA miR-31
por: Viré, Emmanuelle, et al.
Publicado: (2014) -
The EMSY threonine 207 phospho-site is required for EMSY-driven suppression of DNA damage repair
por: Jelinic, Petar, et al.
Publicado: (2017) -
A novel mechanism of regulation of the anti-metastatic miR-31 by EMSY in breast cancer
por: Mulrane, Laoighse, et al.
Publicado: (2014) -
EMSY links breast cancer gene 2 to the 'Royal Family'
por: Yao, Jun, et al.
Publicado: (2004) -
Clinical importance of the EMSY gene expression and polymorphisms in ovarian cancer
por: Dansonka-Mieszkowska, Agnieszka, et al.
Publicado: (2018)